API drugmakers face fines in China's Tianjin for price fixing
MLex Summary: Chinese drugmaker Jinyao Pharmaceutical said Tianjin's antitrust regulator imposed a 26.4 million yuan ($3.6 million) fine on the company for fixing the prices of active pharmaceutical ingredient dexamethasone sodium...To view the full article, register now.
Already a subscriber? Click here to view full article